FDA Inspection
Robert Joseph Jeanfreau, MDRobert Joseph Jeanfreau, MD – FDA Inspection, Feb 25, 2022
Record Details
This FDA Inspection record concerns Robert Joseph Jeanfreau, MD, with an inspection on February 25, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Robert Joseph Jeanfreau, MD
- Inspection Date
- February 25, 2022
- Product Type
- Drugs
View Company Profile
ID · 70e73edb-8f58-4b2c-979e-86c4f2d74f05
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1163046
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Robert Joseph Jeanfreau, MD
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 8, 2012 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| January 20, 2009 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Robert Joseph Jeanfreau, MD
- FDA Inspection 772509 - 2012-02-08
- FDA Inspection 557514 - 2009-01-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.